Company Filing History:

8 out of 818

Boston University

Years Active: 2005-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11236169 - Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke (2022-02-01),

2. 10934358 - Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery (2021-03-02),

3. 10849966 - Methods for treating netosis and neutrophil activation (2020-12-01),

4. 10568970 - Theranostic compositions and uses thereof (2020-02-25),

5. 10202457 - Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke (2019-02-12),

6. 10040856 - Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery (2018-08-07),

7. 8956609 - Roles for Dual Endothelin-1/Angiotensin II Receptor (Dear) in hypertension and angiogenesis (2015-02-17),

8. 7919093 - Roles for dual endothelin-1/angiotensin II receptor (Dear) in hypertension and angiogenesis (2011-04-05),

9. 6844483 - Method of assaying modulators of hypertension (2005-01-18),

Title: The Innovative Contributions of Victoria L M Herrera

Introduction

Victoria L M Herrera is a distinguished inventor based in Westwood, MA (US), known for his significant contributions to the field of biomedical research. With a total of nine patents to his name, Herrera has made remarkable strides in developing therapies and imaging techniques for cancer and stroke.

Latest Patents

Among his latest patents is the "Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke." This patent describes novel compositions that include anti-DEspR antibodies and fragments derived from specific anti-DEspR variant antibodies. These compositions are designed for various therapeutic applications, including diagnostic and imaging methods. Another notable patent is "Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness." This invention also focuses on anti-DEspR antibodies and their utility in diagnostic imaging and therapeutic applications.

Career Highlights

Victoria L M Herrera has worked with prominent institutions such as Boston University and Nomi Corporation. His work has significantly impacted the development of targeted therapies and imaging techniques in the medical field.

Collaborations

Some of his notable coworkers include Nelson Ruiz-Opazo and Francis Joseph Carr, who have collaborated with him on various research projects.

Conclusion

Victoria L M Herrera's innovative work in the field of biomedical research has led to significant advancements in cancer and stroke therapies. His contributions continue to influence the development of effective diagnostic and therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.